MCKENZIE JONES: Open Payments
NPI 1396419180 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 41 payments from 12 companies in 2025. Trend: 2023 $2,188 · 2024 $1,535 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 11 | $167 |
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| ABBVIE INC. | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $23 |
| Biogen, Inc. | 1 | $20 |
Products named: REXULTI, VRAYLAR, CAPLYTA, ABILIFY MAINTENA, INVEGA SUSTENNA, COBENFY, UZEDY, Jornay PM.
Industry payments across NE — which companies pay providers there.
